DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to heal wounds in rare skin disease
Disease control Recruiting nowThis study tests whether adding IV IgG treatment to standard VYJUVEK therapy can help wounds heal faster and reduce blistering in people with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic skin condition. Eight participants will receive IV IgG and be monitored …
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: M. Peter Marinkovich • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New eye drops aim to stop painful cornea scratches in rare skin disease
Disease control Recruiting nowThis study tests an eye drop called KB803 for people with dystrophic epidermolysis bullosa (DEB), a rare genetic condition that causes fragile skin and repeated cornea scratches. The trial will include 16 people aged 6 months and older. Each person will receive both KB803 and a p…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Krystal Biotech, Inc. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New gel could help heal wounds in rare 'Butterfly Skin' disease
Disease control Recruiting nowThis study tests a new topical treatment called Ev.FV for people with dystrophic epidermolysis bullosa (EB), a rare genetic condition that causes fragile skin and painful blisters. The treatment uses tiny particles from cells to help wounds heal faster. About 20 participants will…
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1, PHASE2 • Sponsor: Isfahan University of Medical Sciences • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New gel could ease wound pain for butterfly children
Symptom relief Recruiting nowThis study tests a gel called TCP-25 on people with a rare skin condition called epidermolysis bullosa (EB), which causes fragile skin and painful blisters. Researchers want to see if the gel helps wounds close faster and reduces pain during bandage changes. About 32 people aged …
Matched conditions: DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE2 • Sponsor: Xinnate AB • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC